Table 2.
Absorption, Distribution, Metabolism, and Excretion (ADME) parameters related to the theopapuamides A-D pharmacokinetics.
Theopapuamides | ||||
---|---|---|---|---|
A | B | C | D | |
GI absorption | Low | Low | Low | Low |
BBB permeable | No | No | No | No |
P-gp substrate | Yes | Yes | Yes | Yes |
CYP1A2 inhibitor | No | No | No | No |
CYP2C19 inhibitor | No | No | No | No |
CYP2C9 inhibitor | No | No | No | No |
CYP2D6 inhibitor | No | No | No | No |
CYP3A4 inhibitor | No | No | No | No |
Log K (skin permeation) | −19.30 | −19.37 | −18.28 | −17.98 |
(cm/s) |